Li et al. (3) reported a progressive and significant increase in the nuclear expression of Skp2, moving from melanocytic nevi to melanoma in situ, primary cutaneous melanoma and metastatic melanoma respectively, suggesting that this protein is implicated in melanoma progression. This evidence concerns the gene SKP2 and metastatic melanoma.